One major concern when using Vidalista 40 in conjunction with alpha-blockers is the risk of a significant drop in blood pressure. Both types of medications promote vasodilation—Vidalista 40 by inhibiting PDE5 and alpha-blockers by blocking alpha-adrenergic receptors. This combined effect can lead to an excessive lowering of blood pressure, resulting in symptoms such as dizziness, fainting, and blurred vision. This condition, known as orthostatic hypotension, can be particularly dangerous as it may lead to falls or other serious complications.
https://www.flatmeds.com/product/vidalista-40-mg/